XFOR logo

X4 Pharmaceuticals (XFOR) Accounts Payable

Annual Accounts Payable

$8.95 M
+$1.17 M+15.04%

December 31, 2023


Summary


Performance

XFOR Accounts Payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherXFORbalance sheetmetrics:

Quarterly Accounts Payable

$8.58 M
+$591.00 K+7.40%

September 30, 2024


Summary


Performance

XFOR Quarterly Accounts Payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherXFORbalance sheetmetrics:

Accounts Payable Formula

Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers

XFOR Accounts Payable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+15.0%0.0%
3 y3 years+184.6%0.0%
5 y5 years+1541.7%+403.4%

XFOR Accounts Payable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+108.9%-4.1%+140.3%
5 y5-yearat high+328.5%-4.1%+587.3%
alltimeall timeat high+2015.1%-4.1%+1473.8%

X4 Pharmaceuticals Accounts Payable History

DateAnnualQuarterly
Sep 2024
-
$8.58 M(+7.4%)
Jun 2024
-
$7.99 M(-10.6%)
Mar 2024
-
$8.94 M(-0.1%)
Dec 2023
$8.95 M(+15.0%)
$8.95 M(+10.0%)
Sep 2023
-
$8.13 M(+59.2%)
Jun 2023
-
$5.11 M(-14.8%)
Mar 2023
-
$5.99 M(-23.0%)
Dec 2022
$7.78 M(+81.6%)
$7.78 M(+104.7%)
Sep 2022
-
$3.80 M(+3.3%)
Jun 2022
-
$3.68 M(+3.0%)
Mar 2022
-
$3.57 M(-16.7%)
Dec 2021
$4.28 M(+36.2%)
$4.28 M(+76.7%)
Sep 2021
-
$2.42 M(-4.1%)
Jun 2021
-
$2.53 M(-18.2%)
Mar 2021
-
$3.09 M(-1.7%)
DateAnnualQuarterly
Dec 2020
$3.14 M(+50.6%)
$3.14 M(-19.2%)
Sep 2020
-
$3.89 M(+111.7%)
Jun 2020
-
$1.84 M(+47.3%)
Mar 2020
-
$1.25 M(-40.2%)
Dec 2019
$2.09 M(+283.1%)
$2.09 M(+22.5%)
Sep 2019
-
$1.70 M(-45.0%)
Jun 2019
-
$3.10 M(-49.5%)
Mar 2019
-
$6.13 M(+1025.1%)
Dec 2018
$545.00 K(-71.2%)
$545.00 K(-74.4%)
Sep 2018
-
$2.13 M(-0.5%)
Jun 2018
-
$2.14 M(+92.9%)
Mar 2018
-
$1.11 M(-41.5%)
Dec 2017
$1.89 M(+15.1%)
$1.89 M(-54.5%)
Sep 2017
-
$4.16 M(+153.1%)
Dec 2016
$1.65 M(+288.9%)
$1.65 M
Dec 2015
$423.00 K
-

FAQ

  • What is X4 Pharmaceuticals annual accounts payable?
  • What is the all time high annual accounts payable for X4 Pharmaceuticals?
  • What is X4 Pharmaceuticals annual accounts payable year-on-year change?
  • What is X4 Pharmaceuticals quarterly accounts payable?
  • What is the all time high quarterly accounts payable for X4 Pharmaceuticals?
  • What is X4 Pharmaceuticals quarterly accounts payable year-on-year change?

What is X4 Pharmaceuticals annual accounts payable?

The current annual accounts payable of XFOR is $8.95 M

What is the all time high annual accounts payable for X4 Pharmaceuticals?

X4 Pharmaceuticals all-time high annual accounts payable is $8.95 M

What is X4 Pharmaceuticals annual accounts payable year-on-year change?

Over the past year, XFOR annual accounts payable has changed by +$1.17 M (+15.04%)

What is X4 Pharmaceuticals quarterly accounts payable?

The current quarterly accounts payable of XFOR is $8.58 M

What is the all time high quarterly accounts payable for X4 Pharmaceuticals?

X4 Pharmaceuticals all-time high quarterly accounts payable is $8.95 M

What is X4 Pharmaceuticals quarterly accounts payable year-on-year change?

Over the past year, XFOR quarterly accounts payable has changed by $0.00 (0.00%)